Neurocrine Biosciences shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by DAFNA Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.0M | 70k | 115.22 |
| 2024-06-30 | $9.9M | 72k | 137.67 |
| 2024-03-31 | $9.9M | 72k | 137.92 |
| 2023-12-31 | $9.6M | 73k | 131.76 |
| 2023-09-30 | $8.3M | 74k | 112.50 |
| 2023-06-30 | $7.0M | 75k | 94.30 |
| 2023-03-31 | $7.6M | 75k | 101.22 |
| 2022-12-31 | $8.7M | 73k | 119.44 |
| 2022-09-30 | $8.5M | 80k | 106.21 |
| 2022-06-30 | $8.1M | 83k | 97.48 |
| 2022-03-31 | $7.8M | 84k | 93.75 |
| 2021-12-31 | $7.1M | 84k | 85.17 |
| 2021-09-30 | $8.1M | 85k | 95.91 |
| 2021-06-30 | $7.2M | 74k | 97.32 |
| 2021-03-31 | $7.2M | 74k | 97.25 |
| 2020-12-31 | $8.8M | 92k | 95.85 |
| 2020-09-30 | $8.7M | 90k | 96.16 |
| 2020-06-30 | $8.9M | 73k | 121.99 |
| 2020-03-31 | $6.9M | 80k | 86.55 |
| 2019-12-31 | $6.6M | 61k | 107.49 |
| 2019-09-30 | $5.8M | 65k | 90.11 |
| 2019-06-30 | $5.5M | 65k | 84.43 |
| 2019-03-31 | $4.8M | 55k | 88.10 |
| 2018-12-31 | $3.9M | 55k | 71.41 |
| 2018-09-30 | $5.0M | 41k | 122.95 |
| 2018-06-30 | $4.5M | 46k | 98.25 |
| 2018-03-31 | $4.5M | 55k | 82.92 |
| 2017-12-31 | $4.2M | 55k | 77.58 |
| 2017-09-30 | $3.3M | 55k | 61.28 |
| 2017-06-30 | $2.5M | 55k | 45.99 |
| 2017-03-31 | $2.5M | 59k | 43.29 |
| 2016-12-31 | $2.6M | 66k | 38.71 |
| 2016-09-30 | $3.2M | 64k | 50.63 |
| 2016-06-30 | $3.4M | 76k | 45.46 |
| 2016-03-31 | $3.0M | 76k | 39.55 |
| 2014-09-30 | $1.0M | 66k | 15.66 |